GB2617183B - Alcohol degrading compositions and uses thereof - Google Patents

Alcohol degrading compositions and uses thereof Download PDF

Info

Publication number
GB2617183B
GB2617183B GB2204716.1A GB202204716A GB2617183B GB 2617183 B GB2617183 B GB 2617183B GB 202204716 A GB202204716 A GB 202204716A GB 2617183 B GB2617183 B GB 2617183B
Authority
GB
United Kingdom
Prior art keywords
alcohol degrading
degrading compositions
compositions
alcohol
degrading
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB2204716.1A
Other languages
English (en)
Other versions
GB202204716D0 (en
GB2617183A (en
Inventor
De Faire Johan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
De Faire Medical AB
Original Assignee
De Faire Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Faire Medical AB filed Critical De Faire Medical AB
Priority to GB2204716.1A priority Critical patent/GB2617183B/en
Publication of GB202204716D0 publication Critical patent/GB202204716D0/en
Priority to PCT/EP2023/058370 priority patent/WO2023187097A1/en
Priority to US18/851,739 priority patent/US20250213626A1/en
Priority to EP23717428.9A priority patent/EP4499048A1/en
Priority to JP2024557929A priority patent/JP2025511131A/ja
Priority to KR1020247035468A priority patent/KR20240167863A/ko
Priority to AU2023246874A priority patent/AU2023246874A1/en
Priority to CA3246845A priority patent/CA3246845A1/en
Priority to CN202380039669.9A priority patent/CN119343134A/zh
Publication of GB2617183A publication Critical patent/GB2617183A/en
Application granted granted Critical
Publication of GB2617183B publication Critical patent/GB2617183B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Wood Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
GB2204716.1A 2022-03-31 2022-03-31 Alcohol degrading compositions and uses thereof Active GB2617183B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB2204716.1A GB2617183B (en) 2022-03-31 2022-03-31 Alcohol degrading compositions and uses thereof
AU2023246874A AU2023246874A1 (en) 2022-03-31 2023-03-30 Alcohol degrading compositions and uses thereof
US18/851,739 US20250213626A1 (en) 2022-03-31 2023-03-30 Alcohol degrading compositions and uses thereof
EP23717428.9A EP4499048A1 (en) 2022-03-31 2023-03-30 Alcohol degrading compositions and uses thereof
JP2024557929A JP2025511131A (ja) 2022-03-31 2023-03-30 アルコール分解組成物及びその使用
KR1020247035468A KR20240167863A (ko) 2022-03-31 2023-03-30 알코올 분해 조성물 및 그의 용도
PCT/EP2023/058370 WO2023187097A1 (en) 2022-03-31 2023-03-30 Alcohol degrading compositions and uses thereof
CA3246845A CA3246845A1 (en) 2022-03-31 2023-03-30 ALCOHOL DEGRADATION COMPOUNDS AND THEIR USES
CN202380039669.9A CN119343134A (zh) 2022-03-31 2023-03-30 醇降解组合物及其用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2204716.1A GB2617183B (en) 2022-03-31 2022-03-31 Alcohol degrading compositions and uses thereof

Publications (3)

Publication Number Publication Date
GB202204716D0 GB202204716D0 (en) 2022-05-18
GB2617183A GB2617183A (en) 2023-10-04
GB2617183B true GB2617183B (en) 2024-09-04

Family

ID=81581547

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2204716.1A Active GB2617183B (en) 2022-03-31 2022-03-31 Alcohol degrading compositions and uses thereof

Country Status (9)

Country Link
US (1) US20250213626A1 (https=)
EP (1) EP4499048A1 (https=)
JP (1) JP2025511131A (https=)
KR (1) KR20240167863A (https=)
CN (1) CN119343134A (https=)
AU (1) AU2023246874A1 (https=)
CA (1) CA3246845A1 (https=)
GB (1) GB2617183B (https=)
WO (1) WO2023187097A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2621976B (en) * 2022-08-19 2024-11-20 De Faire Medical Ab Compositions for use in treating and/or preventing type 2 diabetes, pre-diabetes, and/or a symptom thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03272657A (ja) * 1990-03-20 1991-12-04 Nippon Haiga Kenkyusho:Kk アルコール耐性付与醗酵物の製造方法及びアルコール耐性付与醗酵食品
JP2002161045A (ja) * 2000-09-18 2002-06-04 Toyo Hakko:Kk アルコール代謝向上剤及び肝障害低減剤
CN101731630A (zh) * 2010-01-22 2010-06-16 完美（中国）日用品有限公司 一种具有解酒、护肝功效的保健食品
KR20190091053A (ko) * 2018-01-26 2019-08-05 주식회사 케이엠에프 아미노산 강화분말을 유효성분으로 포함하는 숙취개선용 조성물 및 그 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100661032B1 (ko) * 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
FI127823B (en) * 2015-03-06 2019-03-15 Biohit Oyj Composition for preventing hangover symptoms
KR101853603B1 (ko) * 2017-05-18 2018-05-02 주식회사 쎌바이오텍 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03272657A (ja) * 1990-03-20 1991-12-04 Nippon Haiga Kenkyusho:Kk アルコール耐性付与醗酵物の製造方法及びアルコール耐性付与醗酵食品
JP2002161045A (ja) * 2000-09-18 2002-06-04 Toyo Hakko:Kk アルコール代謝向上剤及び肝障害低減剤
CN101731630A (zh) * 2010-01-22 2010-06-16 完美（中国）日用品有限公司 一种具有解酒、护肝功效的保健食品
KR20190091053A (ko) * 2018-01-26 2019-08-05 주식회사 케이엠에프 아미노산 강화분말을 유효성분으로 포함하는 숙취개선용 조성물 및 그 제조방법

Also Published As

Publication number Publication date
JP2025511131A (ja) 2025-04-15
AU2023246874A1 (en) 2024-09-19
KR20240167863A (ko) 2024-11-28
CA3246845A1 (en) 2023-10-05
GB202204716D0 (en) 2022-05-18
GB2617183A (en) 2023-10-04
EP4499048A1 (en) 2025-02-05
WO2023187097A1 (en) 2023-10-05
US20250213626A1 (en) 2025-07-03
CN119343134A (zh) 2025-01-21

Similar Documents

Publication Publication Date Title
CA3259912A1 (en) Compositions of Tirzepatide and their use
GB2617183B (en) Alcohol degrading compositions and uses thereof
GB202411091D0 (en) Compositions and uses
GB202215065D0 (en) Compositions and uses thereof
GB202209335D0 (en) Compositions and uses thereof
CA3298248A1 (en) Compositions comprising difluoropropene and uses thereof
GB202002926D0 (en) Compositions and uses thereof
CA3295099A1 (en) Compositions and uses thereof
CA3295097A1 (en) Compositions and uses thereof
CA3292483A1 (en) Maribavir compositions and uses thereof
AU2023903761A0 (en) Compositions and uses thereof
HK40128580A (en) Compositions and uses thereof
HK40127555A (en) Compositions and uses thereof
AU2022901597A0 (en) Compositions and uses thereof
AU2022901030A0 (en) Compositions and uses thereof
AU2022900574A0 (en) Compositions and uses thereof
GB202411057D0 (en) Compositions and uses
GB202215064D0 (en) Compositions and uses thereof
GB202213726D0 (en) Compositions and uses thereof
GB202210107D0 (en) Compositions and uses thereof
GB202210106D0 (en) Compositions and uses thereof
GB202210105D0 (en) Compositions and uses thereof
GB202205222D0 (en) Compositions and uses thereof
HK40119185A (en) Tirzepatide compositions and use
CA3304052A1 (en) Vaccine compositions and uses thereof